The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood ...

The first patient blood samples, just weeks away, will open a new chapter in medicine’s ongoing search for a therapy that ...

It measures levels of rare cancer cells that tumors shed into the blood Men with higher levels may need more aggressive ...

Glioblastoma, a rare but devastating form of brain cancer, has long been considered virtually incurable. With a grim ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

For some patients with breast cancer, ctDNA may have the potential to predict disease relapse after they have undergone ...

T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach ...

A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer ...

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond ...

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

The non-invasive test, which measures circulating tumor cells in the blood, can predict treatment response, disease ...

A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer. A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which ...